The Einstein/MMC CFAR Virology Core provides essential and highly used services to CFAR investigators that supply the infrastructure, resources, assays and techniques that permit Einstein/MMC CFAR basic and clinical investigators to investigate different aspects of HIV-1 replication in vitro and in vivo. This greatly facilitates their research efforts by allowing them to quickly and efficiently perform experiments that they could not otherwise do. For investigators who have experience in handling HIV-1, the BSLS/Virology core provides a dedicated BSL3 facility that contains the essential equipment for culturing HIV-1 under the appropriate biosafety conditions. For investigators whose research program requires them to culture HIV-1 but who do not have experience culturing HIV-1, the BSL3/Virology Core trains them in the various techniques and protocols required to safely handle and reliably culture HIV-1. Regular workshops are presented to teach investigators techniques for the measurement of p24 antigen by ELISA, co-culture of HIV-1 from PBMCs, performance of HIV-1 fusion assays using luciferase reporter pseudotyped HIV-1, measurement of plasma HIV-1 RNA levels, and determining viral titers using reporter cell lines. For clinical investigators, the core provides up-to-date, clinically relevant virological assays such as the quantification of plasma HIV-1 RNA and HCV RNA, isolation and phenotypic analysis of HIV, and isolation and storage of PBMC, plasma and/or serum from study patients. The Core also provides support for a wide range of molecular biology techniques including custom vector and plasmid design and construction, DNA sub-cloning and amplification, site-directed mutagenesis, large-scale expression of recombinant HIV, human or other pathogen proteins, siRNA interference construct design, and the heteroduplex mobility assay.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-EC-A)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Albert Einstein College of Medicine
United States
Zip Code
Gupta, Sanchit; Lounsbury, David W; Patel, Viraj V (2017) Low Awareness and Use of Preexposure Prophylaxis in a Diverse Online Sample of Men Who Have Sex With Men in New York City. J Assoc Nurses AIDS Care 28:27-33
Megra, Bezawit W; Eugenin, Eliseo A; Berman, Joan W (2017) The Role of Shed PrPc in the Neuropathogenesis of HIV Infection. J Immunol 199:224-232
Fox, Aaron D; Sohler, Nancy L; Frost, Taeko et al. (2017) Development and evaluation of a community-based buprenorphine treatment intervention. Harm Reduct J 14:23
Calderon, Tina M; Williams, Dionna W; Lopez, Lillie et al. (2017) Dopamine Increases CD14+CD16+ Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis. J Neuroimmune Pharmacol 12:353-370
Vilch├Ęze, Catherine; Hartman, Travis; Weinrick, Brian et al. (2017) Enhanced respiration prevents drug tolerance and drug resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 114:4495-4500
Usyk, Mykhaylo; Zolnik, Christine P; Patel, Hitesh et al. (2017) Novel ITS1 Fungal Primers for Characterization of the Mycobiome. mSphere 2:
Felsen, Uriel R; Cunningham, Chinazo O; Heo, Moonseong et al. (2017) Expanded HIV Testing Strategy Leveraging the Electronic Medical Record Uncovers Undiagnosed Infection Among Hospitalized Patients. J Acquir Immune Defic Syndr 75:27-34
Shah, N Sarita; Auld, Sara C; Brust, James C M et al. (2017) Transmission of Extensively Drug-Resistant Tuberculosis in South Africa. N Engl J Med 376:243-253
Heo, Moonseong; Litwin, Alain H; Blackstock, Oni et al. (2017) Sample size determinations for group-based randomized clinical trials with different levels of data hierarchy between experimental and control arms. Stat Methods Med Res 26:399-413
Bien, Cedric H; Patel, Viraj V; Blackstock, Oni J et al. (2017) Reaching Key Populations: PrEP Uptake in an Urban Health Care System in the Bronx, New York. AIDS Behav 21:1309-1314

Showing the most recent 10 out of 517 publications